Romania – Blood-grouping reagents – UTS Reagents and Consumables

Opportunity description

Framework agreement for the supply of UTS Reagents and Consumables. The contracting authority will respond clearly and completely to all requests for clarification/additional information on the 11th day before the deadline for submission of tenders/applications (the clear and complete responses to all requests for clarification will be attached on the 11th day before the deadline for submission of tenders). Note: The contracting authority is not required to respond to requests for clarification/additional information that were not submitted within the deadline established in Section I.1 of the Data Sheet. Number of days before the deadline for submission of tenders/applications by which clarifications may be requested: 18. min. qty. fw. agr. 12 sets/ max. fw. agr. 40 sets, min. qty. subs. ctr. 3 sets/ max. subs. ctr. 7 sets The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 1092 cards/ max. fw. agr. 4608 cards, min. qty. subs. ctr. 288 cards/ max. subs. ctr. 768 cards The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 2160 cards/ max. fw. agr. 10992 cards, min. qty. subs. ctr. 480 cards/ max. subs. ctr. 2160 cards The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 960 cards/ max. fw. agr. 11952 cards, min. qty. subs. ctr. 240 cards/ max. subs. ctr. 1968 cards The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 10 sets/ max. fw. agr. 100 sets, min. qty. subs. ctr. 1 set/ max. subs. ctr. 12 sets The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 720 cards/ max. fw. agr. 6240 cards, min. qty. subs. ctr. 192 cards/ max. subs. ctr. 960 cards The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 2400 cards/ max. fw. agr. 8880 cards, min. qty. subs. ctr. 480 cards/ max. subs. ctr. 1440 cards The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 4800 cards/ max. fw. agr. 17760 cards, min. qty. subs. ctr. 960 cards/ max. subs. ctr. 2880 cards The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 120 vials/ max. fw. agr. 600 vials, min. qty. subs. ctr. 20 vials/ max. subs. ctr. 70 vials The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr.4 vials/ max. fw. agr.30 vials, min. qty. subs. ctr. 1 vial/ max. subs. ctr. 4 vials The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 12 cards / max. fw. agr. 384 cards, min. qty. subs. ctr. 12 cards/ max. subs. ctr. 24 cards The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 20 sets / max. fw. agr. 40 sets, min. qty. subs. ctr. 2 sets/ max. subs. ctr. 8 sets The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 12 cards / max. fw. agr. 60 cards, min. qty. subs. ctr.12 cards/ max. subs. ctr. 24 cards The contracting authority uniformly applies the “best price-quality ratio” criterion to lots 1-15. The reagents and consumables that are the subject of the procedure, lots 1-15, will be purchased from the same supplier, which will tender all reagents in items 1-15 and will present a Certificate from the reagent manufacturer attesting to the compatibility of the reagents offered with the Biorad line installed at our unit. The reagents in items 1-15 are interdependent—they are card-type reagents that require auxiliary reagents (diluents and red blood cells) from the same manufacturer in accordance with the instructions for use, under which condition the reagents and tests can be validated. The tests cannot be validated using reagents from different manufacturers. The reagents in items 1-15 are used for determinations necessary for choosing a compatible blood component. In the event of an error, if reagents from different manufacturers are used, it is impossible to conduct an analysis of the case and no manufacturer will assume liability. min. qty. fw. agr. 30 sets / max. fw. agr. 140 sets, min. qty. subs. ctr. 4 sets/ max. subs. ctr. 24 sets min. qty. fw. agr. 7000 cards / max. fw. agr. 25000 cards, min. qty. subs. ctr. 2000 cards/ max. subs. ctr. 6000 cards min. qty. fw. agr. 20000 pcs / max. fw. agr. 100000 pcs, min. qty. subs. ctr. 8000 pcs/ max. subs. ctr. 20000 pcs min. qty. fw. agr. 60000 pcs / max. fw. agr. 150000 pcs, min. qty. subs. ctr. 10000 pcs/ max. subs. ctr. 20000 pcs Procedure: open. Estimated value: 2,334,228 RON. Review the original TED notice for the complete requirement, lots, amendments and attachments.